<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font21">hepatitis </span>
   <span class="font20">the </span>
   <span class="font17">for </span>
   <span class="font14">elimination </span>
   <span class="font13">with </span>
   <span class="font13">investment </span>
   <span class="font13">health </span>
   <span class="font11">are </span>
   <span class="font11">treatment </span>
   <span class="font11">Health </span>
   <span class="font11">WHO </span>
   <span class="font11">activities </span>
   <span class="font11">viral </span>
   <span class="font11">The </span>
   <span class="font11">from </span>
   <span class="font11">global </span>
   <span class="font11">(). </span>
   <span class="font11">World </span>
   <span class="font11">that </span>
   <span class="font11">costs </span>
   <span class="font11">Hepatitis </span>
   <span class="font11">programmes </span>
   <span class="font11">national </span>
   <span class="font11">achieve </span>
   <span class="font11">support </span>
   <span class="font11">has </span>
   <span class="font11">funding </span>
   <span class="font11">{background </span>
   <span class="font11">countries </span>
   <span class="font11">disease </span>
   <span class="font11">liver </span>
   <span class="font11">million </span>
   <span class="font11">through </span>
   <span class="font11">vaccination </span>
   <span class="font10">also </span>
   <span class="font10">targets </span>
   <span class="font10">birth </span>
   <span class="font10">impact </span>
   <span class="font10">people </span>
   <span class="font10">such </span>
   <span class="font10">would </span>
   <span class="font10">Global </span>
   <span class="font10">have </span>
   <span class="font10">increase </span>
   <span class="font10">coverage </span>
   <span class="font10">dose </span>
   <span class="font10">margin </span>
   <span class="font10">systems </span>
   <span class="font10">care </span>
   <span class="font10">existing </span>
   <span class="font10">{border-style </span>
   <span class="font10">[], </span>
   <span class="font10">chronic </span>
   <span class="font10">diagnostics </span>
   <span class="font10">framework </span>
   <span class="font10">estimated </span>
   <span class="font10">including </span>
   <span class="font10">model </span>
   <span class="font10">other </span>
   <span class="font10">public </span>
   <span class="font10">px;} </span>
   <span class="font10">reduce </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">financing </span>
   <span class="font10">transmission </span>
   <span class="font10">can </span>
   <span class="font10">cost-effectiveness </span>
   <span class="font10">data </span>
   <span class="font10">international </span>
   <span class="font10">resource </span>
   <span class="font10">testing </span>
   <span class="font10">this </span>
   <span class="font10">HBV </span>
   <span class="font10">high </span>
   <span class="font10">access </span>
   <span class="font10">improve </span>
   <span class="font10">low </span>
   <span class="font10">prevention </span>
   <span class="font10">screening </span>
   <span class="font10">HIV </span>
   <span class="font10">Hepatol </span>
   <span class="font10">US$. </span>
   <span class="font10">analysis </span>
   <span class="font10">been </span>
   <span class="font10">living </span>
   <span class="font10">may </span>
   <span class="font10">these </span>
   <span class="font10">available </span>
   <span class="font10">billion </span>
   <span class="font10">infection </span>
   <span class="font10">required </span>
   <span class="font10">research </span>
   <span class="font10">strategies </span>
   <span class="font10">supported </span>
   <span class="font10">virus </span>
   <span class="font10">will </span>
   <span class="font10">COVID- </span>
   <span class="font10">However, </span>
   <span class="font10">International </span>
   <span class="font10">case </span>
   <span class="font10">cost </span>
   <span class="font10">deaths </span>
   <span class="font10">developed </span>
   <span class="font10">economic </span>
   <span class="font10">into </span>
   <span class="font10">models </span>
   <span class="font10">monitoring </span>
   <span class="font10">than </span>
   <span class="font10">universal </span>
   <span class="font10">vaccine </span>
   <span class="font10">()() </span>
   <span class="font10">Gilead </span>
   <span class="font10">HIV, </span>
   <span class="font10">SDG </span>
   <span class="font10">South </span>
   <span class="font10">Viral </span>
   <span class="font10">between </span>
   <span class="font10">burden </span>
   <span class="font10">cancer </span>
   <span class="font10">cirrhosis </span>
   <span class="font10">cure </span>
   <span class="font10">current </span>
   <span class="font10">development </span>
   <span class="font10">elimination. </span>
   <span class="font10">essential </span>
   <span class="font10">modelling </span>
   <span class="font10">new </span>
   <span class="font10">rapid </span>
   <span class="font10">risk </span>
   <span class="font10">society </span>
   <span class="font10">state </span>
   <span class="font10">there </span>
   <span class="font10">(), </span>
   <span class="font10">Disease </span>
   <span class="font10">Essential </span>
   <span class="font10">GAVI </span>
   <span class="font10">Investment </span>
   <span class="font10">National </span>
   <span class="font10">Organization. </span>
   <span class="font10">Table </span>
   <span class="font10">This </span>
   <span class="font10">affordable </span>
   <span class="font10">among </span>
   <span class="font10">community </span>
   <span class="font10">compared </span>
   <span class="font10">currently </span>
   <span class="font10">key </span>
   <span class="font10">local </span>
   <span class="font10">medicines </span>
   <span class="font10">mortality </span>
   <span class="font10">need </span>
   <span class="font10">prevalence </span>
   <span class="font10">resources </span>
   <span class="font10">scale-up </span>
   <span class="font10">strategy </span>
   <span class="font10">system </span>
   <span class="font10">transition </span>
   <span class="font10">use </span>
   <span class="font10">using </span>
   <span class="font10">Cost-effectiveness </span>
   <span class="font10">Fund </span>
   <span class="font10">LMICs </span>
   <span class="font10">PoC </span>
   <span class="font10">Study </span>
   <span class="font10">achievement </span>
   <span class="font10">across </span>
   <span class="font10">advocacy </span>
   <span class="font10">approach </span>
   <span class="font10">civil </span>
   <span class="font10">critical </span>
   <span class="font10">diagnosis </span>
   <span class="font10">diseases </span>
   <span class="font10">due </span>
   <span class="font10">facilitate </span>
   <span class="font10">had </span>
   <span class="font10">management </span>
   <span class="font10">mother-to-child </span>
   <span class="font10">not </span>
   <span class="font10">novel </span>
   <span class="font10">policy </span>
   <span class="font10">progress </span>
   <span class="font10">px; </span>
   <span class="font10">scenario </span>
   <span class="font10">services </span>
   <span class="font10">target </span>
   <span class="font10">towards </span>
   <span class="font10">was </span>
   <span class="font10">which </span>
   <span class="font10">{font-family </span>
   <span class="font10">Brazil, </span>
   <span class="font10">Burden </span>
   <span class="font10">Gastroenterol </span>
   <span class="font10">Glob </span>
   <span class="font10">Markov </span>
   <span class="font10">Ministry </span>
   <span class="font10">TDF </span>
   <span class="font10">additional </span>
   <span class="font10">affordability </span>
   <span class="font10">against </span>
   <span class="font10">blood </span>
   <span class="font10">community-based </span>
   <span class="font10">countries, </span>
   <span class="font10">deliver </span>
   <span class="font10">domestic </span>
   <span class="font10">drug </span>
   <span class="font10">effective </span>
   <span class="font10">font-size </span>
   <span class="font10">fund </span>
   <span class="font10">funds </span>
   <span class="font10">greatest </span>
   <span class="font10">implementation </span>
   <span class="font10">integration </span>
   <span class="font10">investments </span>
   <span class="font10">likely </span>
   <span class="font10">low-income </span>
   <span class="font10">major </span>
   <span class="font10">partnerships </span>
   <span class="font10">received </span>
   <span class="font10">strengthening </span>
   <span class="font10">surveillance </span>
   <span class="font10">those </span>
   <span class="font10">tuberculosis </span>
   <span class="font10">were </span>
   <span class="font10">when </span>
   <span class="font10">within </span>
   <span class="font10">&amp;amp; </span>
   <span class="font10">Development </span>
   <span class="font10">Financing </span>
   <span class="font10">Geneva, </span>
   <span class="font10">Healthee </span>
   <span class="font10">Innovation </span>
   <span class="font10">Innovative </span>
   <span class="font10">List </span>
   <span class="font10">Medicines </span>
   <span class="font10">Nayagam </span>
   <span class="font10">Strategic </span>
   <span class="font10">Strategy </span>
   <span class="font10">Sustainable </span>
   <span class="font10">achieving </span>
   <span class="font10">all </span>
   <span class="font10">awareness </span>
   <span class="font10">chain </span>
   <span class="font10">child </span>
   <span class="font10">delivery </span>
   <span class="font10">demand </span>
   <span class="font10">donors </span>
   <span class="font10">double; </span>
   <span class="font10">from: </span>
   <span class="font10">generic </span>
   <span class="font10">guidelines </span>
   <span class="font10">infrastructure </span>
   <span class="font10">its </span>
   <span class="font10">lack </span>
   <span class="font10">levels </span>
   <span class="font10">leverage </span>
   <span class="font10">malaria </span>
   <span class="font10">many </span>
   <span class="font10">middle-income </span>
   <span class="font10">more </span>
   <span class="font10">needed </span>
   <span class="font10">population </span>
   <span class="font10">programs </span>
   <span class="font10">projected </span>
   <span class="font10">provide </span>
   <span class="font10">quo </span>
   <span class="font10">rates </span>
   <span class="font10">return </span>
   <span class="font10">should </span>
   <span class="font10">states </span>
   <span class="font10">status </span>
   <span class="font10">treatment, </span>
   <span class="font10">well </span>
   <span class="font10">where </span>
   <span class="font10">Africa </span>
   <span class="font10">B-related </span>
   <span class="font10">DNA </span>
   <span class="font10">Elsevier </span>
   <span class="font10">Geneva: </span>
   <span class="font10">Impact </span>
   <span class="font10">Key </span>
   <span class="font10">Lancet </span>
   <span class="font10">Model </span>
   <span class="font10">Modelling </span>
   <span class="font10">Organisation. </span>
   <span class="font10">Organization </span>
   <span class="font10">Organization; </span>
   <span class="font10">Policy </span>
   <span class="font10">Prevention </span>
   <span class="font10">Regional </span>
   <span class="font10">Summit </span>
   <span class="font10">achieved </span>
   <span class="font10">availability </span>
   <span class="font10">avert </span>
   <span class="font10">barriers </span>
   <span class="font10">based </span>
   <span class="font10">being </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cost-effective </span>
   <span class="font10">could </span>
   <span class="font10">dedicated </span>
   <span class="font10">diagnosis, </span>
   <span class="font10">diagnostic </span>
   <span class="font10">evaluation </span>
   <span class="font10">finance </span>
   <span class="font10">financial </span>
   <span class="font10">grant </span>
   <span class="font10">how </span>
   <span class="font10">identifies </span>
   <span class="font10">infant </span>
   <span class="font10">innovative </span>
   <span class="font10">investigator-initiated </span>
   <span class="font10">life </span>
   <span class="font10">maternal </span>
   <span class="font10">member </span>
   <span class="font10">only </span>
   <span class="font10">patients </span>
   <span class="font10">potential </span>
   <span class="font10">private </span>
   <span class="font10">production </span>
   <span class="font10">program </span>
   <span class="font10">programmes, </span>
   <span class="font10">public-private </span>
   <span class="font10">reduction </span>
   <span class="font10">remains </span>
   <span class="font10">response </span>
   <span class="font10">returns </span>
   <span class="font10">settings </span>
   <span class="font10">solid; </span>
   <span class="font10">sources </span>
   <span class="font10">test </span>
   <span class="font10">total </span>
   <span class="font10">used </span>
   <span class="font10">years </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">.%, </span>
   <span class="font10">.Drug </span>
   <span class="font10">Association </span>
   <span class="font10">Australia </span>
   <span class="font10">Cost </span>
   <span class="font10">Diagnostics </span>
   <span class="font10">European </span>
   <span class="font10">Foundation </span>
   <span class="font10">Framework </span>
   <span class="font10">Pacific </span>
   <span class="font10">Panel </span>
   <span class="font10">Rwanda </span>
   <span class="font10">Sciences, </span>
   <span class="font10">Scott </span>
   <span class="font10">Switzerland: </span>
   <span class="font10">There </span>
   <span class="font10">Tordrup </span>
   <span class="font10">Virus </span>
   <span class="font10">[Available </span>
   <span class="font10">activities. </span>
   <span class="font10">allow </span>
   <span class="font10">annual </span>
   <span class="font10">antenatal </span>
   <span class="font10">antiviral </span>
   <span class="font10">benefits </span>
   <span class="font10">bold </span>
   <span class="font10">both </span>
   <span class="font10">centre </span>
   <span class="font10">challenges </span>
   <span class="font10">clear </span>
   <span class="font10">combined </span>
   <span class="font10">commitment </span>
   <span class="font10">country </span>
   <span class="font10">coupled </span>
   <span class="font10">courier; </span>
   <span class="font10">coverage. </span>
   <span class="font10">cross-sectoral </span>
   <span class="font10">determine </span>
   <span class="font10">discrimination </span>
   <span class="font10">drive </span>
   <span class="font10">efficiencies </span>
   <span class="font10">elimination, </span>
   <span class="font10">em; </span>
   <span class="font10">ensure </span>
   <span class="font10">entecavir </span>
   <span class="font10">epidemiologic </span>
   <span class="font10">fees </span>
   <span class="font10">further </span>
   <span class="font10">future </span>
   <span class="font10">general </span>
   <span class="font10">governments </span>
   <span class="font10">healthcare </span>
   <span class="font10">hepatocellular </span>
   <span class="font10">improved </span>
   <span class="font10">include </span>
   <span class="font10">income </span>
   <span class="font10">infection, </span>
   <span class="font10">infections </span>
   <span class="font10">infectious </span>
   <span class="font10">limited </span>
   <span class="font10">linkage </span>
   <span class="font10">list </span>
   <span class="font10">low-cost </span>
   <span class="font10">manuscript. </span>
   <span class="font10">modelled </span>
   <span class="font10">most </span>
   <span class="font10">non-communicable </span>
   <span class="font10">outcomes </span>
   <span class="font10">outlines </span>
   <span class="font10">outside </span>
   <span class="font10">over </span>
   <span class="font10">particularly </span>
   <span class="font10">political </span>
   <span class="font10">price </span>
   <span class="font10">procurement </span>
   <span class="font10">programme </span>
   <span class="font10">programmes. </span>
   <span class="font10">progression </span>
   <span class="font10">provided </span>
   <span class="font10">pt;} </span>
   <span class="font10">published </span>
   <span class="font10">reduces </span>
   <span class="font10">regional </span>
   <span class="font10">resulting </span>
   <span class="font10">safety </span>
   <span class="font10">scale </span>
   <span class="font10">stigma </span>
   <span class="font10">study </span>
   <span class="font10">studyLancet </span>
   <span class="font10">substantial </span>
   <span class="font10">successfully </span>
   <span class="font10">supply </span>
   <span class="font10">syphilis </span>
   <span class="font10">systematic </span>
   <span class="font10">targets. </span>
   <span class="font10">temperature </span>
   <span class="font10">tests </span>
   <span class="font10">therefore </span>
   <span class="font10">training </span>
   <span class="font10">under </span>
   <span class="font10">utilization </span>
   <span class="font10">vaccines </span>
   <span class="font10">work </span>
   <span class="font10">worldwide </span>
   <span class="font10">â€" </span>
  </p>
 </body>
</html>
